Ying‐Ming Chiu

526 total citations
28 papers, 363 citations indexed

About

Ying‐Ming Chiu is a scholar working on Rheumatology, Epidemiology and Hepatology. According to data from OpenAlex, Ying‐Ming Chiu has authored 28 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Rheumatology, 7 papers in Epidemiology and 7 papers in Hepatology. Recurrent topics in Ying‐Ming Chiu's work include Hepatitis C virus research (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Hepatitis B Virus Studies (5 papers). Ying‐Ming Chiu is often cited by papers focused on Hepatitis C virus research (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers) and Hepatitis B Virus Studies (5 papers). Ying‐Ming Chiu collaborates with scholars based in Taiwan, United States and Spain. Ying‐Ming Chiu's co-authors include Der‐Yuan Chen, Hsu‐Heng Yen, Kuo‐Lung Lai, Joung‐Liang Lan, Der‐Yuan Chen, Jung‐Der Wang, Hui‐Chu Lang, Gregory J. Tsay, Dong‐Chen Shieh and K. Arnold Chan and has published in prestigious journals such as PLoS ONE, Scientific Reports and Acta Psychiatrica Scandinavica.

In The Last Decade

Ying‐Ming Chiu

25 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying‐Ming Chiu Taiwan 11 144 98 79 63 45 28 363
Haruyo Iwadate Japan 11 171 1.2× 92 0.9× 87 1.1× 56 0.9× 40 0.9× 25 316
Kanokrat Nantiruj Thailand 11 133 0.9× 129 1.3× 75 0.9× 49 0.8× 46 1.0× 18 380
Neeraj Das India 11 68 0.5× 99 1.0× 28 0.4× 99 1.6× 77 1.7× 25 350
Feliciano Chanana Paquissi Angola 7 36 0.3× 121 1.2× 63 0.8× 80 1.3× 55 1.2× 9 299
Phillip Ruiz United States 9 40 0.3× 86 0.9× 101 1.3× 52 0.8× 58 1.3× 14 345
Dam Kim South Korea 16 330 2.3× 43 0.4× 21 0.3× 59 0.9× 56 1.2× 43 600
David L. Hyslop United States 7 196 1.4× 61 0.6× 12 0.2× 54 0.9× 18 0.4× 14 394
Magdalena Rogalska Poland 9 21 0.1× 144 1.5× 150 1.9× 95 1.5× 26 0.6× 24 353
Jhon Prieto United States 10 37 0.3× 159 1.6× 140 1.8× 31 0.5× 61 1.4× 22 510
Junfeng Zhang China 10 28 0.2× 249 2.5× 79 1.0× 19 0.3× 38 0.8× 25 425

Countries citing papers authored by Ying‐Ming Chiu

Since Specialization
Citations

This map shows the geographic impact of Ying‐Ming Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying‐Ming Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying‐Ming Chiu more than expected).

Fields of papers citing papers by Ying‐Ming Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying‐Ming Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying‐Ming Chiu. The network helps show where Ying‐Ming Chiu may publish in the future.

Co-authorship network of co-authors of Ying‐Ming Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Ying‐Ming Chiu. A scholar is included among the top collaborators of Ying‐Ming Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying‐Ming Chiu. Ying‐Ming Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiu, Ying‐Ming, Yi Yang, Jane Pei‐Chen Chang, et al.. (2025). Life Expectancy, Loss of Life Expectancy, and Lifetime Costs in Bipolar Disorder: A Nationwide Population‐Based Study. Acta Psychiatrica Scandinavica. 152(5). 350–359.
2.
3.
Chiu, Hsien‐Yi & Ying‐Ming Chiu. (2025). Risk of Cardiovascular Morbidity and Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Survivors. JAMA Dermatology. 161(4). 391–391. 1 indexed citations
4.
5.
Chiu, Ying‐Ming, Wei‐Lieh Huang, Shi‐Heng Wang, et al.. (2024). Estimating expected years of life lost of psychiatric disorders in Taiwan: A Nationwide cohort study. General Hospital Psychiatry. 91. 25–32. 1 indexed citations
6.
7.
8.
Tsai, Yi‐Giien, et al.. (2021). Lupus nephritis with corticosteroid responsiveness: molecular changes of CD46-mediated type 1 regulatory T cells. Pediatric Research. 92(4). 1099–1107. 3 indexed citations
9.
Wu, Chao‐Yi, Wen‐Lang Fan, Ying‐Ming Chiu, et al.. (2021). Lipopolysaccharide stimulation test on cultured PBMCs assists the discrimination of cryopyrin-associated periodic syndrome from systemic juvenile idiopathic arthritis. Scientific Reports. 11(1). 11903–11903. 2 indexed citations
10.
Chiu, Ying‐Ming & Der‐Yuan Chen. (2019). Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics. Expert Review of Clinical Immunology. 16(2). 207–228. 61 indexed citations
11.
12.
Chiu, Ying‐Ming, Tin‐Yun Ho, Dong‐Chen Shieh, et al.. (2018). Gallic Acid Induces Apoptosis in Human Gastric Adenocarcinoma Cells. Anticancer Research. 38(4). 2057–2067. 38 indexed citations
13.
Chiu, Ying‐Ming, Mei‐Shu Lai, & K. Arnold Chan. (2018). Commensurate incidence and outcomes of liver enzyme elevation between anti-tumor necrosis factor users with or without prior hepatitis B virus infections. PLoS ONE. 13(4). e0196210–e0196210. 7 indexed citations
14.
Yen, Hsu‐Heng, et al.. (2017). Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis.. PubMed. 35(5). 831–836. 36 indexed citations
15.
Chiu, Ying‐Ming, Mei‐Shu Lai, & K. Arnold Chan. (2017). Assessing risk of liver enzyme elevation in patients with immune-mediated diseases and different hepatitis B virus serostatus receiving anti-TNF agents: a nested case-control study. Arthritis Research & Therapy. 19(1). 214–214. 11 indexed citations
16.
17.
Chiu, Ying‐Ming, et al.. (2016). Frequency of Lost to Follow-Up and Associated Factors for Patients with Rheumatic Diseases. PLoS ONE. 11(3). e0150816–e0150816. 10 indexed citations
18.
Chiu, Ying‐Ming, et al.. (2011). Pancreatitis, Panniculitis, and Polyarthritis Syndrome Presenting With Gouty Arthritis: A Case Report. Journal of Medical Cases. 2(3). 110–112. 1 indexed citations
19.
Lai, Kuo‐Lung & Ying‐Ming Chiu. (2011). Role of Ultrasonography in Diagnosing Gouty Arthritis. Journal of Medical Ultrasound. 19(1). 7–13. 26 indexed citations
20.
Lin, Chun‐Ju, et al.. (2010). UNUSUAL MACULOPATHY SECONDARY TO HYPERGAMMAGLOBULINEMIA IN A PATIENT WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Retinal Cases & Brief Reports. 6(1). 27–29. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haruyo Iwadate Breakdown of academic impact, for papers by Kanokrat Nantiruj Breakdown of academic impact, for papers by Neeraj Das Breakdown of academic impact, for papers by Feliciano Chanana Paquissi Breakdown of academic impact, for papers by Phillip Ruiz Breakdown of academic impact, for papers by Dam Kim Breakdown of academic impact, for papers by David L. Hyslop Breakdown of academic impact, for papers by Magdalena Rogalska Breakdown of academic impact, for papers by Jhon Prieto Breakdown of academic impact, for papers by Junfeng Zhang
Rankless by CCL
2026